Global Blood and Plasma Collections and Use 2023–2024: Trends, Regulations, and Market Insights
Dana Miloslavich, Director Of Research at The Marketing Research Bureau Inc, shared on LinkedIn:
“The Marketing Research Bureau is pleased to announce the completion of the following report:
GLOBAL BLOOD AND PLASMA COLLECTIONS AND USE – 2023/2024
This new MRB report presents a global overview of blood collections and an analysis of all the sources of plasma used for fractionation from over 85 countries.
Plasma collection regulations and the historical context for those regulations are detailed in many countries, including plasma recovered from whole blood donations, as well as source plasma collected by public/non-profit entities and private companies.
Today, most of the plasma for fractionation is collected in the United States, but high collection costs constitute a cause of concern for those markets that largely depend on U.S. plasma.
Therefore, a good understanding of the potential for sourcing plasma from outside the U.S. is essential for planning and forecasting. In addition, awareness of plasma volumes collected in each individual country helps to inform both its current self-sufficiency level and quantities of imported plasma proteins needed to address its domestic market needs.
In addition to data on plasma for fractionation and whole blood collections, quantitative information on other blood components is included for those countries where such figures could be accessed.
Presented data are based on an extensive survey conducted by MRB in over 85 countries in 2023 and 2024. In addition to 2024 full-year figures for plasma fractionation, the report provides historical data going back 10 or more years as available”
Read more here.
More insights on Hemostasis Today.
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda